TY - JOUR
T1 - Factors that influence use of a home cardiorespiratory monitor for infants
T2 - The collaborative home infant monitoring evaluation
AU - Silvestri, Jean M.
AU - Lister, George
AU - Corwin, Michael J.
AU - Smok-Pearsall, Sheilah M.
AU - Baird, Terry M.
AU - Crowell, David H.
AU - Cantey-Kiser, Jean
AU - Hunt, Carl E.
AU - Tinsley, Larry
AU - Palmer, Paula H.
AU - Mendenhall, Rebecca S.
AU - Hoppenbrouwers, Toke T.
AU - Neuman, Michael R.
AU - Weese-Mayer, Debra E.
AU - Willinger, Marian
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2005/1
Y1 - 2005/1
N2 - Background: As part of the Collaborative Home Infant Monitoring Evaluation, a home monitor was developed to record breathing, heart rate, other physiologic variables, and the time the monitor was used. Objective: To determine the frequency of monitor use, factors that influence use, and validity of a model developed to predict use. Design: We developed a model to predict monitor use using multiple linear regression analysis; we then tested the validity of this model to predict adherence for the first week of monitoring and for the subsequent 4-week period (weeks 2-5). Setting: Clinical research centers in Chicago, Ill; Cleveland, Ohio; Honolulu, Hawaii; Los Angeles, Calif; and Toledo, Ohio. Patients: Preterm infants, infants younger than 1 month with a history of autopsy-confirmed sudden infant death syndrome in a sibling, and infants with an idiopathic apparent life-threatening event were divided into 2 cohorts based on enrollment date. Main Outcome Measure: Mean hours of monitor use per week. Results: In cohort 1, the variables available before monitoring were only weakly associated with total hours of monitor use in weeks 2 to 5 (total model r 2 = 0.08). However, when hours of monitor use in week 1 were included as a variable to predict monitor use in weeks 2 to 5, the r2 increased to 0.64 for hours of monitor use per week. Conclusions: Our data show that monitor use in the first week was the most important variable for predicting subsequent monitor use. The study suggests that a major focus of home monitoring should be adherence in the first week, although it remains to be tested whether this adherence can be altered.
AB - Background: As part of the Collaborative Home Infant Monitoring Evaluation, a home monitor was developed to record breathing, heart rate, other physiologic variables, and the time the monitor was used. Objective: To determine the frequency of monitor use, factors that influence use, and validity of a model developed to predict use. Design: We developed a model to predict monitor use using multiple linear regression analysis; we then tested the validity of this model to predict adherence for the first week of monitoring and for the subsequent 4-week period (weeks 2-5). Setting: Clinical research centers in Chicago, Ill; Cleveland, Ohio; Honolulu, Hawaii; Los Angeles, Calif; and Toledo, Ohio. Patients: Preterm infants, infants younger than 1 month with a history of autopsy-confirmed sudden infant death syndrome in a sibling, and infants with an idiopathic apparent life-threatening event were divided into 2 cohorts based on enrollment date. Main Outcome Measure: Mean hours of monitor use per week. Results: In cohort 1, the variables available before monitoring were only weakly associated with total hours of monitor use in weeks 2 to 5 (total model r 2 = 0.08). However, when hours of monitor use in week 1 were included as a variable to predict monitor use in weeks 2 to 5, the r2 increased to 0.64 for hours of monitor use per week. Conclusions: Our data show that monitor use in the first week was the most important variable for predicting subsequent monitor use. The study suggests that a major focus of home monitoring should be adherence in the first week, although it remains to be tested whether this adherence can be altered.
UR - http://www.scopus.com/inward/record.url?scp=19944427330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944427330&partnerID=8YFLogxK
U2 - 10.1001/archpedi.159.1.18
DO - 10.1001/archpedi.159.1.18
M3 - Article
C2 - 15630053
AN - SCOPUS:19944427330
VL - 159
SP - 18
EP - 24
JO - JAMA Pediatrics
JF - JAMA Pediatrics
SN - 2168-6203
IS - 1
ER -